Literature DB >> 2785393

Enhancement of HIV replication and giant cell formation by tumor necrosis factor.

T Matsuyama1, H Yoshiyama, Y Hamamoto, N Yamamoto, G Soma, D Mizuno, N Kobayashi.   

Abstract

Human T cell lines Molt-4, Jurkat, and TLOm-1 were infected by HIV-1 in the presence of various concentrations of r-TNF. The infectivity of HIV-1 was monitored by an indirect immunofluorescence method using anti-HIV-1-positive human serum. We found that r-TNF enhanced the replication of HIV-1. HIV-1-induced giant cell formation between HIV-1 chronically infected Molt-4 cells and HIV-1-uninfected Molt-4 cells was accelerated by r-TNF. The median tissue culture infectious doses (TCID50) of HIV-1 determined in the presence of TNF revealed that TNF apparently accelerated the time of the appearance of CPE but did not affect final titer of HIV-1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785393     DOI: 10.1089/aid.1989.5.139

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  10 in total

Review 1.  Is TNF involved in the progression of AIDS?

Authors:  N Kobayashi; Y Hamamoto; N Yamamoto
Journal:  Virus Genes       Date:  1990-07       Impact factor: 2.332

2.  Increased HIV-1 production in chronically infected H9 cells grown in protein-free medium.

Authors:  J Cinatl; J Cinatl; H Rabenau; U Ebener; B Kornhuber; H W Doerr
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

Authors:  Marein A W P de Jong; Lot de Witte; Menno J Oudhoff; Sonja I Gringhuis; Philippe Gallay; Teunis B H Geijtenbeek
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

4.  Imbalance in cytokine production by whole blood related to presence of cytopathogenic HIV-1 strains in HIV-1-infected patients.

Authors:  S Benyoucef; G Lion; Y Gérard; P Wattré; D De Groote; D Hober
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

5.  Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication.

Authors:  N Kobayashi; Y Hamamoto; N Yamamoto; A Ishii; M Yonehara; S Yonehara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Production of tumor necrosis factors by human T cell lines infected with HTLV-1 may cause their high susceptibility to human immunodeficiency virus infection.

Authors:  N Kobayashi; Y Hamamoto; N Yamamoto
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

7.  Elevated levels of circulating tumor necrosis factor alpha in human immunodeficiency virus type 1-infected Africans living in Sweden.

Authors:  A Sönnerborg; S Ayehunie; I Julander
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

8.  Differential replication of human immunodeficiency virus type 1 in CD8- and CD8+ subsets of natural killer cells: relationship to cytokine production pattern.

Authors:  F D Tóth; P Mosborg-Petersen; J Kiss; G Aboagye-Mathiesen; M Zdravkovic; H Hager; P Ebbesen
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.

Authors:  G Poli; A Kinter; J S Justement; J H Kehrl; P Bressler; S Stanley; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  Effect of a recombinant HIV gp160 vaccine on monokine production.

Authors:  D P Dooley; R A Cox; D J Looney
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.